Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Integrated Animals is a virtual database currently indexing available animal strains and mutants from: AGSC (Ambystoma), BCBC (mice), BDSC (flies), European Xenopus Resource Center (frog), The National Xenopus Resource (frog), Xenopus Express (frog), CWRU Cystic Fibrosis Mouse Models (mice), DGGR (flies), FlyBase (flies), IMSR (mice), MGI (mice), MMRRC (mice), NSRRC (pig), RGD (rats), Sperm Stem Cell Libraries for Biological Research (rats), Tetrahymena Stock Center (Tetrahymena), WormBase (worms), XGSC (Xiphophorus), ZFIN (zebrafish), and ZIRC (zebrafish). Note, the IMSR data is linked, but users may need to re-execute the search if the top mouse is not returned properly.
Note: BCBC is no longer in service, so the links may not be functional.
| Organism Name | Proper Citation | Species | Synonyms |
Notes |
Phenotype | Affected Gene | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
STOCK Prnptm1Cwe Tg(Prnp)940Zbz/Cnrm Resource Report Resource Website Issue Issue |
RRID:IMSR_EM:02027 | Mus musculus |
PrPmyc |
gene symbol note: prion protein|transgene insertion 940; University Hospital Zurich; mutant strain: Prnp|Tg(Prnp)940Zbz | prion protein|transgene insertion 940; University Hospital Zurich | targeted mutation 1; Charles Weissmann|transgene insertion 940; University Hospital Zurich | EM:02027 | European Mouse Mutant Archive | EMMA | embryo | 2026-07-24 10:29:41 | 0 | ||||
|
FVB.129P2-Frat1tm1Brn/Cnrm Resource Report Resource Website Issue |
RRID:IMSR_EM:02140 | Mus musculus |
FVB.129P2-Frat1 |
gene symbol note: frequently rearranged in advanced T cell lymphomas; mutant strain: Frat1 | frequently rearranged in advanced T cell lymphomas | targeted mutation 1; Anton Berns | EM:02140 | European Mouse Mutant Archive | EMMA | embryo | 2026-07-24 10:29:42 | 0 | ||||
|
STOCK Rettm1Cos/Kctt Resource Report Resource Website Issue Issue |
RRID:IMSR_EM:02081 | Mus musculus |
Ret KO. Cg-Ret |
gene symbol note: ret proto-oncogene; mutant strain: Ret | ret proto-oncogene | targeted mutation 1; Frank Costantini | EM:02081 | European Mouse Mutant Archive | EMMA | embryo | 2026-07-24 10:29:41 | 0 | ||||
|
CByIco.129S7-Ifngtm1Ts/Cnrm Resource Report Resource Website Issue |
RRID:IMSR_EM:02106 | Mus musculus |
BALB/cByJIco IFNg-/-. CByIco.129S7-Ifng |
gene symbol note: interferon gamma; mutant strain: Ifng | interferon gamma | targeted mutation 1; Timothy Stewart | EM:02106 | European Mouse Mutant Archive | EMMA | embryo | 2026-07-24 10:29:41 | 0 | ||||
|
B6;129S7-Prnptm1Cwe Tg(Igh-15B3Vh/Ighm*a)502Zbz/Cnrm Resource Report Resource Website Issue Issue |
RRID:IMSR_EM:02154 | Mus musculus |
B6129-Prnp |
gene symbol note: prion protein|transgene insertion 502; Universitatsspital Zurich; Biologisches Zentrallaboratorium; mutant strain: Prnp|Tg(Igh-15B3Vh/Ighm*a)502Zbz | prion protein|transgene insertion 502; Universitatsspital Zurich; Biologisches Zentrallaboratorium | targeted mutation 1; Charles Weissmann|transgene insertion 502; Universitatsspital Zurich; Biologisches Zentrallaboratorium | EM:02154 | European Mouse Mutant Archive | EMMA | embryo | 2026-07-24 10:29:42 | 0 | ||||
|
B10ScSn.BXSB-(D1Mit3-D1Mit235) Chr YBXSB/MpJ/BjmjrH Resource Report Resource Website Issue |
RRID:IMSR_EM:02280 | Mus musculus | B10.Yaa.Bxs4(20-48) | gene symbol note: accelerated autoimmunity and lymphoproliferation transposition; mutant strain: Yaa | accelerated autoimmunity and lymphoproliferation transposition | accelerated autoimmunity and lymphoproliferation | EM:02280 | European Mouse Mutant Archive | EMMA | sperm | MGI:5494444, IMSR_HAR:3417 | 2026-07-24 10:29:43 | 0 | |||
|
B10ScSn.BXSB-(D1Mit235-D1Mit1000) Chr YBXSB/MpJ/BjmjrH Resource Report Resource Website Issue |
RRID:IMSR_EM:02278 | Mus musculus | gene symbol note: accelerated autoimmunity and lymphoproliferation transposition; mutant strain: Yaa | accelerated autoimmunity and lymphoproliferation transposition | accelerated autoimmunity and lymphoproliferation | EM:02278 | European Mouse Mutant Archive | EMMA | sperm | MGI:5494438, IMSR_HAR:3418 | 2026-07-24 10:29:43 | 0 | ||||
|
B10ScSn.BXSB-(D1Mit123-D1Mit1000) Chr YBXSB/MpJ/BjmjrH Resource Report Resource Website Issue |
RRID:IMSR_EM:02279 | Mus musculus | B10.Yaa.Bxs1.4(40-67) | gene symbol note: accelerated autoimmunity and lymphoproliferation transposition; mutant strain: Yaa | accelerated autoimmunity and lymphoproliferation transposition | accelerated autoimmunity and lymphoproliferation | EM:02279 | European Mouse Mutant Archive | EMMA | sperm | MGI:5494443, IMSR_HAR:3415 | 2026-07-24 10:29:43 | 0 | |||
|
B10ScSn.BXSB-(D1Mit33-D1Mit223) Chr YBXSB/MpJ/BjmjrH Resource Report Resource Website Issue |
RRID:IMSR_EM:02276 | Mus musculus | B10.Yaa.Bxs3(160-190) | gene symbol note: accelerated autoimmunity and lymphoproliferation transposition; mutant strain: Yaa | accelerated autoimmunity and lymphoproliferation transposition | accelerated autoimmunity and lymphoproliferation | EM:02276 | European Mouse Mutant Archive | EMMA | sperm | MGI:5494323, IMSR_HAR:3420 | 2026-07-24 10:29:43 | 0 | |||
|
B10ScSn.BXSB-(D1Mit303-D1Mit305) Chr YBXSB/MpJ/BjmjrH Resource Report Resource Website Issue |
RRID:IMSR_EM:02277 | Mus musculus | B10.Yaa.Bxs1(63-89) | gene symbol note: accelerated autoimmunity and lymphoproliferation transposition; mutant strain: Yaa | accelerated autoimmunity and lymphoproliferation transposition | accelerated autoimmunity and lymphoproliferation | EM:02277 | European Mouse Mutant Archive | EMMA | sperm | MGI:5494326, IMSR_HAR:3419 | 2026-07-24 10:29:43 | 0 | |||
|
C3H101H-Pax3Sp-2H/H Resource Report Resource Website Issue |
RRID:IMSR_EM:02535 | Mus musculus | gene symbol note: paired box 3; mutant strain: Pax3 | paired box 3 | splotch 2 Harwell | EM:02535 | European Mouse Mutant Archive | EMMA | embryo | MGI:3579063, IMSR_HAR:239 | 2026-07-24 10:29:46 | 0 | ||||
|
FVB.129-Cdkn2atm1Rdp Ptentm1Ffur/Mmucd Resource Report Resource Website Issue |
RRID:MMRRC_043553-UCD | Mus musculus | Research areas: Cancer, Developmental Biology, Neurobiology; Mutation Type: Targeted Mutation ; Collection: | kyphosis [MP:0000160]| extramedullary hematopoiesis [MP:0000240]| increased cell proliferation [MP:0000351]| decreased cell proliferation [MP:0000352]| abnormal intestine morphology [MP:0000477]| enlarged liver [MP:0000599]| abnormal branching of the mammary ductal tree [MP:0000662]| abnormal spleen morphology [MP:0000689]| enlarged spleen [MP:0000691]| enlarged lymph nodes [MP:0000702]| abnormal myogenesis [MP:0000729]| increased satellite cell number [MP:0000730]| paralysis [MP:0000753]| abnormal retinal photoreceptor morphology [MP:0001004]| abnormal prostate gland morphology [MP:0001158]| hyperpigmentation [MP:0001188]| skin lesions [MP:0001212]| epidermal hyperplasia [MP:0001222]| hyperkeratosis [MP:0001242]| decreased body weight [MP:0001262]| decreased body size [MP:0001265]| increased metastatic potential [MP:0001272]| microphthalmia [MP:0001297]| cataract [MP:0001304]| abnormal somite development [MP:0001688]| embryonic growth arrest [MP:0001730]| mammary gland duct hyperplasia [MP:0001885]| hydroencephaly [MP:0001891]| increased tumor incidence [MP:0002020]| increased B cell derived lymphoma incidence [MP:0002023]| increased leukemia incidence [MP:0002026]| increased lung adenocarcinoma incidence [MP:0002027]| increased neurofibrosarcoma incidence [MP:0002030]| increased sarcoma incidence [MP:0002032]| increased rhabdomyosarcoma incidence [MP:0002036]| premature death [MP:0002083]| abnormal spleen red pulp morphology [MP:0002356]| abnormal cell cycle [MP:0003077]| abnormal telomere length [MP:0003155]| increased neuron apoptosis [MP:0003203]| testicular atrophy [MP:0003205]| abnormal forebrain development [MP:0003232]| decreased tumor growth/size [MP:0003447]| abnormal keratinocyte physiology [MP:0003453]| increased hemangiosarcoma incidence [MP:0003667]| premature aging [MP:0003786]| skeletal muscle interstitial fibrosis [MP:0003851]| abnormal skin development [MP:0003941]| increased squamous cell carcinoma incidence [MP:0004207]| increased cellular sensitivity to ionizing radiation [MP:0004227]| increased incidence of tumors by chemical induction [MP:0004499]| increased incidence of tumors by UV-induction [MP:0004501]| abnormal posterior eye segment morphology [MP:0005195]| abnormal skin physiology [MP:0005501]| abnormal lens development [MP:0005545]| abnormal cell physiology [MP:0005621]| abnormal retinal neuronal layer morphology [MP:0006069]| abnormal common myeloid progenitor cell morphology [MP:0006410]| delayed cellular replicative senescence [MP:0008009]| increased lung tumor incidence [MP:0008014]| abnormal male germ cell apoptosis [MP:0008280]| increased spleen white pulp amount [MP:0008478]| increased pancreatic ductal adenocarcinoma incidence [MP:0009151]| increased pancreas tumor incidence [MP:0009153]| increased prostate gland adenocarcinoma incidence [MP:0009220]| increased brain tumor incidence [MP:0009277]| abnormal mammary gland duct morphology [MP:0009503]| increased keratinocyte proliferation [MP:0009583]| skin fibrosis [MP:0009932]| increased melanoma incidence [MP:0010275]| increased intraocular melanoma incidence [MP:0010276]| increased glioma incidence [MP:0010278]| increased skin tumor incidence [MP:0010300]| decreased tumor latency [MP:0010308]| increased oligodendroglioma incidence [MP:0010312]| increased cutaneous melanoma incidence [MP:0010322]| increased fibrosarcoma incidence [MP:0010363]| persistent hyperplastic primary vitreous [MP:0010711]| increased glioblastoma incidence [MP:0010727]| prenatal lethality [MP:0011091]| complete penetrance [MP:0011703]| increased fibroblast proliferation [MP:0011748]| intestinal fibrosis [MP:0012431] | PtenCdkn2a | 043553-UCD | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_43553-UCD, MMRRC_043553, MMRRC_43553 | 2026-07-25 09:43:33 | 0 | ||||
|
MRL.Cg-Aicdatm1Hon Faslpr/DiazMmnc Resource Report Resource Website Issue |
RRID:MMRRC_043606-UNC | Mus musculus | Research areas: Immunology and Inflammation, Models for Human Disease, Obesity, Research Tools; Mutation Type: Targeted Mutation ; Collection: | decreased IgG level [MP:0001805]| decreased IgA level [MP:0001807]| abnormal B cell physiology [MP:0002459]| increased IgM level [MP:0002494]| spontaneous chromosome breakage [MP:0004029]| induced chromosome breakage [MP:0004030]| abnormal somatic hypermutation frequency [MP:0004815]| abnormal class switch recombination [MP:0004816]| increased germinal center B cell number [MP:0008177]| decreased IgG1 level [MP:0008495]| decreased IgG2a level [MP:0008496]| decreased IgG2b level [MP:0008497]| decreased IgG3 level [MP:0008498]| abnormal immunoglobulin heavy chain V(D)J recombination [MP:0008760]| chromosomal instability [MP:0008866]| increased susceptibility to bacterial infection induced morbidity/mortality [MP:0009788]| abnormal stria vascularis morphology [MP:0000048]| decreased bone mineral density [MP:0000063]| abnormal trabecular bone morphology [MP:0000130]| abnormal vertebrae morphology [MP:0000137]| increased leukocyte cell number [MP:0000218]| increased neutrophil cell number [MP:0000219]| abnormal erythropoiesis [MP:0000245]| abnormal heart morphology [MP:0000266]| abnormal aorta morphology [MP:0000272]| abnormal mast cell morphology [MP:0000359]| abnormal hair follicle morphology [MP:0000377]| abnormal hair follicle orientation [MP:0000383]| alopecia [MP:0000414]| sparse hair [MP:0000416]| ruffled hair [MP:0000420]| cortical renal glomerulopathies [MP:0000523]| abnormal femur morphology [MP:0000559]| abnormal hepatocyte morphology [MP:0000607]| abnormal liver physiology [MP:0000609]| abnormal thyroid gland morphology [MP:0000681]| abnormal immune system morphology [MP:0000685]| enlarged spleen [MP:0000691]| spleen hyperplasia [MP:0000693]| abnormal lymph node size [MP:0000701]| enlarged lymph nodes [MP:0000702]| enlarged thymus [MP:0000709]| abnormal lymphocyte cell number [MP:0000717]| abnormal cerebellum morphology [MP:0000849]| small cerebellum [MP:0000852]| abnormal cerebellar foliation [MP:0000857]| decreased Purkinje cell number [MP:0000880]| thin cerebellar molecular layer [MP:0000890]| demyelination [MP:0000921]| abnormal stellate ganglion morphology [MP:0001017]| arrest of spermatogenesis [MP:0001155]| abnormal skin condition [MP:0001191]| dermatitis [MP:0001194]| skin lesions [MP:0001212]| thick epidermis [MP:0001219]| epidermal necrosis [MP:0001220]| increased body weight [MP:0001260]| decreased body size [MP:0001265]| absent vibrissae [MP:0001284]| abnormal lacrimal gland morphology [MP:0001346]| ataxia [MP:0001393]| impaired coordination [MP:0001405]| abnormal spatial learning [MP:0001463]| abnormal cardiovascular system physiology [MP:0001544]| focal hepatic necrosis [MP:0001656]| extended life span [MP:0001661]| abnormal immune system physiology [MP:0001790]| abnormal humoral immune response [MP:0001800]| arrested B cell differentiation [MP:0001802]| decreased IgG level [MP:0001805]| decreased IgM level [MP:0001806]| decreased IgA level [MP:0001807]| increased activated T cell number [MP:0001829]| decreased activated T cell number [MP:0001830]| autoimmune response [MP:0001844]| brain inflammation [MP:0001847]| conjunctivitis [MP:0001852]| kidney inflammation [MP:0001859]| liver inflammation [MP:0001860]| lung inflammation [MP:0001861]| vascular inflammation [MP:0001863]| vasculitis [MP:0001864]| salivary gland inflammation [MP:0001870]| male infertility [MP:0001925]| female infertility [MP:0001926]| increased tumor incidence [MP:0002020]| premature death [MP:0002083]| abnormal kidney morphology [MP:0002135]| abnormal kidney physiology [MP:0002136]| abnormal gland morphology [MP:0002163]| decreased brain weight [MP:0002175]| abnormal outer ear morphology [MP:0002177]| small lymph nodes [MP:0002217]| abnormal spleen size [MP:0002224]| abnormal airway responsiveness [MP:0002334]| abnormal lymph node morphology [MP:0002339]| abnormal thymus medulla morphology [MP:0002375]| increased susceptibility to bacterial infection [MP:0002412]| increased susceptibility to viral infection [MP:0002418]| abnormal CD4-positive [MP:0002432]| alpha beta T cell morphology [MP:0002435]| abnormal effector T cell morphology [MP:0002444]| abnormal T cell physiology [MP:0002458]| abnormal B cell number [MP:0002460]| decreased immunoglobulin level [MP:0002461]| increased immunoglobulin level [MP:0002490]| abnormal immunoglobulin level [MP:0002492]| decreased IgE level [MP:0002493]| increased IgG level [MP:0002494]| increased IgM level [MP:0002495]| increased IgA level [MP:0002497]| increased IgE level [MP:0002533]| abnormal type III hypersensitivity reaction [MP:0002687]| oligozoospermia [MP:0002722]| abnormal immune system organ morphology [MP:0002743]| glomerulonephritis [MP:0002828]| abnormal renal glomerular capsule morphology [MP:0002871]| albuminuria [MP:0002936]| joint swelling [MP:0002962]| increased urine protein level [MP:0002965]| increased circulating serum albumin level [MP:0003009]| abnormal cytokine secretion [MP:0003204]| decreased neuron apoptosis [MP:0003504]| thyroid inflammation [MP:0003606]| kidney failure [MP:0003628]| abnormal leukocyte adhesion [MP:0003644]| thymus atrophy [MP:0003670]| dilated renal glomerular capsule [MP:0003725]| increased autoantibody level [MP:0003726]| decreased autoantibody level [MP:0003793]| abnormal submandibular gland morphology [MP:0003944]| abnormal T cell subpopulation ratio [MP:0003946]| renal necrosis [MP:0004031]| insulitis [MP:0004111]| abnormal coronary artery morphology [MP:0004153]| increased renal tubule apoptosis [MP:0004367]| abnormal strial intermediate cell morphology [MP:0004368]| abnormal stria vascularis vasculature morphology [MP:0004481]| abnormal conjunctival epithelium morphology [MP:0004696]| abnormal thyroid follicle morphology [MP:0004762]| increased anti-double stranded DNA antibody level [MP:0004771]| increased anti-single stranded DNA antibody level [MP:0004794]| increased anti-nuclear antigen antibody level [MP:0004795]| decreased anti-nuclear antigen antibody level [MP:0004796]| increased anti-histone antibody level [MP:0004797]| increased anti-erythrocyte antigen antibody level [MP:0004798]| decreased anti-double stranded DNA antibody level [MP:0004801]| increased susceptibility to systemic lupus erythematosus [MP:0004802]| decreased susceptibility to systemic lupus erythematosus [MP:0004803]| increased susceptibility to autoimmune diabetes [MP:0004804]| decreased susceptibility to autoimmune diabetes [MP:0004829]| increased anti-chromatin antibody level [MP:0004939]| abnormal B cell morphology [MP:0004952]| increased spleen weight [MP:0004953]| decreased spleen weight [MP:0004955]| increased thymus weight [MP:0004977]| increased B-1 B cell number [MP:0005012]| decreased eosinophil cell number [MP:0005014]| increased B cell number [MP:0005015]| increased T cell number [MP:0005017]| decreased B cell number [MP:0005078]| abnormal cytotoxic T cell physiology [MP:0005089]| decreased double-negative T cell number [MP:0005090]| increased double-negative T cell number [MP:0005094]| abnormal T cell proliferation [MP:0005178]| increased circulating cholesterol level [MP:0005179]| decreased circulating cholesterol level [MP:0005264]| glomerulosclerosis [MP:0005265]| abnormal blood urea nitrogen level [MP:0005325]| abnormal renal glomerulus morphology [MP:0005329]| abnormal myocardium layer morphology [MP:0005338]| atherosclerotic lesions [MP:0005339]| increased susceptibility to atherosclerosis [MP:0005350]| increased susceptibility to autoimmune disorder [MP:0005351]| decreased susceptibility to autoimmune disorder [MP:0005416]| abnormal circulating protein level [MP:0005425]| increased macrophage cell number [MP:0005466]| abnormal T-helper 2 physiology [MP:0005554]| decreased circulating creatinine level [MP:0005565]| increased blood urea nitrogen level [MP:0005566]| decreased blood urea nitrogen level [MP:0005568]| increased circulating total protein level [MP:0005584]| abnormal enzyme/coenzyme activity [MP:0005614]| decreased susceptibility to type III hypersensitivity reaction [MP:0005615]| increased susceptibility to type III hypersensitivity reaction [MP:0005621]| abnormal cell physiology [MP:0006042]| increased apoptosis [MP:0006043]| decreased apoptosis [MP:0006055]| abnormal vascular endothelial cell morphology [MP:0006082]| CNS inflammation [MP:0006099]| thin cerebellar granule layer [MP:0006315]| abnormal urine protein level [MP:0006387]| abnormal T cell number [MP:0008037]| abnormal T cell morphology [MP:0008049]| increased memory T cell number [MP:0008056]| abnormal retinal ganglion cell morphology [MP:0008074]| increased CD4-positive [MP:0008075]| alpha beta T cell number [MP:0008078]| decreased CD4-positive [MP:0008079]| alpha beta T cell number [MP:0008097]| increased CD8-positive [MP:0008098]| alpha-beta T cell number [MP:0008102]| decreased CD8-positive [MP:0008126]| alpha-beta T cell number [MP:0008136]| increased plasma cell number [MP:0008139]| decreased plasma cell number [MP:0008140]| lymph node hyperplasia [MP:0008173]| increased dendritic cell number [MP:0008180]| enlarged Peyer's patches [MP:0008181]| fused podocyte foot processes [MP:0008182]| podocyte foot process effacement [MP:0008189]| increased follicular B cell number [MP:0008190]| abnormal marginal zone B cell morphology [MP:0008206]| increased marginal zone B cell number [MP:0008211]| decreased marginal zone B cell number [MP:0008214]| increased transitional stage B cell number [MP:0008215]| decreased transitional stage B cell number [MP:0008217]| increased B-2 B cell number [MP:0008246]| decreased mature B cell number [MP:0008346]| increased immature B cell number [MP:0008350]| decreased immature B cell number [MP:0008477]| abnormal B cell activation [MP:0008478]| abnormal leukocyte morphology [MP:0008481]| increased gamma-delta T cell number [MP:0008482]| increased gamma-delta intraepithelial T cell number [MP:0008495]| decreased spleen red pulp amount [MP:0008496]| increased spleen white pulp amount [MP:0008497]| increased spleen germinal center number [MP:0008498]| decreased spleen germinal center number [MP:0008499]| decreased IgG1 level [MP:0008500]| decreased IgG2a level [MP:0008501]| decreased IgG2b level [MP:0008502]| decreased IgG3 level [MP:0008542]| increased IgG1 level [MP:0008567]| increased IgG2a level [MP:0008573]| increased IgG2b level [MP:0008578]| increased IgG3 level [MP:0008602]| enlarged cervical lymph nodes [MP:0008626]| decreased interferon-gamma secretion [MP:0008688]| increased circulating interferon-alpha level [MP:0008699]| decreased circulating interferon-gamma level [MP:0008713]| increased circulating interleukin-4 level [MP:0008721]| increased circulating interleukin-5 level [MP:0008722]| decreased interleukin-2 secretion [MP:0008750]| increased interleukin-4 secretion [MP:0008751]| abnormal cytokine level [MP:0008752]| abnormal chemokine level [MP:0008766]| abnormal chemokine secretion [MP:0008769]| abnormal interferon level [MP:0008783]| abnormal interleukin level [MP:0008826]| abnormal tumor necrosis factor level [MP:0008828]| abnormal B cell receptor editing [MP:0008879]| abnormal plasmacytoid dendritic cell physiology [MP:0008880]| decreased B cell apoptosis [MP:0008891]| abnormal splenic cell ratio [MP:0008978]| abnormal lymph node cell ratio [MP:0009338]| submandibular gland inflammation [MP:0009346]| lacrimal gland inflammation [MP:0009642]| decreased hepatocyte apoptosis [MP:0009643]| abnormal vagina weight [MP:0009763]| increased splenocyte number [MP:0010065]| decreased trabecular bone thickness [MP:0010138]| abnormal blood homeostasis [MP:0010760]| abnormal urine homeostasis [MP:0010766]| increased sensitivity to induced morbidity/mortality [MP:0010869]| decreased circulating creatine level [MP:0010879]| arteritis [MP:0010933]| abnormal macrophage chemotaxis [MP:0011081]| abnormal NK cell physiology [MP:0011294]| decreased bone trabecula number [MP:0011320]| decreased trabecular bone volume [MP:0011346]| decreased trabecular bone connectivity density [MP:0011348]| decreased macrophage apoptosis [MP:0011353]| renal glomerulus hypertrophy [MP:0011368]| abnormal glomerular capillary morphology [MP:0011369]| renal tubule atrophy [MP:0011377]| abnormal renal glomerulus basement membrane morphology [MP:0011402]| expanded mesangial matrix [MP:0011409]| increased kidney apoptosis [MP:0011427]| increased renal glomerulus apoptosis [MP:0011440]| renal glomerulus fibrosis [MP:0011445]| renal cast [MP:0011453]| increased renal glomerulus basement membrane thickness [MP:0011483]| mesangial cell hyperplasia [MP:0011506]| increased kidney cell proliferation [MP:0011567]| abnormal renal protein reabsorption [MP:0011742]| abnormal glomerular capillary endothelium morphology [MP:0011967]| renal glomerular synechia [MP:0013452]| glomerular crescent [MP:0013455]| increased renal glomerulus lobularity [MP:0013585]| decreased urine nitrite level [MP:0020332]| increased or absent threshold for auditory brainstem response [MP:0020518]| increased lacrimal gland apoptosis [MP:0020519] | Aicda | 043606-UNC | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_43606-UNC, MMRRC_043606, MMRRC_4366 | 2026-07-25 09:43:34 | 0 | ||||
|
FVB/N.129P2(C)-Cecr2Gt(pGT1)1Hemc/Mmnc Resource Report Resource Website 1+ mentions Issue |
RRID:MMRRC_043821-UNC | Mus musculus | Research areas: Developmental Biology, Models for Human Disease, Neurobiology, Reproduction; Mutation Type: Gene Trap ; Collection: | exencephaly [MP:0000914]| absent eyelids [MP:0001341]| abnormal neural tube morphology [MP:0002151]| delayed neural tube closure [MP:0002621]| perinatal lethality [MP:0011090] | Cecr2 | 043821-UNC | Gene Trap | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_43821-UNC, MMRRC_043821, MMRRC_43821 | 2026-07-25 09:43:37 | 1 | ||||
|
CCrlAlt.129P2-Cecr2Gt(pGTI)1Hemc/Mmnc Resource Report Resource Website 1+ mentions Issue |
RRID:MMRRC_043819-UNC | Mus musculus | Research areas: Developmental Biology, Models for Human Disease, Neurobiology, Reproduction; Mutation Type: Gene Trap ; Collection: | exencephaly [MP:0000914]| absent eyelids [MP:0001341]| abnormal neural tube morphology [MP:0002151]| delayed neural tube closure [MP:0002621]| perinatal lethality [MP:0011090] | Cecr2 | 043819-UNC | Gene Trap | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_43819-UNC, MMRRC_043819, MMRRC_43819 | 2026-07-25 09:43:37 | 1 | ||||
|
MRL.Cg-Igh-8tm1Schr Faslpr/Mmmh Resource Report Resource Website Issue |
RRID:MMRRC_015868-MU | Mus musculus | Research areas: Apoptosis, Cancer, Cardiovascular, Dermatology, Hematology, Immunology and Inflammation, Models for Human Disease; Mutation Type: Targeted Mutation ; Collection: | increased susceptibility to bacterial infection [MP:0002412]| increased IgG level [MP:0002493]| increased IgM level [MP:0002494]| abnormal stria vascularis morphology [MP:0000048]| decreased bone mineral density [MP:0000063]| abnormal trabecular bone morphology [MP:0000130]| abnormal vertebrae morphology [MP:0000137]| increased leukocyte cell number [MP:0000218]| increased neutrophil cell number [MP:0000219]| abnormal erythropoiesis [MP:0000245]| abnormal heart morphology [MP:0000266]| abnormal aorta morphology [MP:0000272]| abnormal mast cell morphology [MP:0000359]| abnormal hair follicle morphology [MP:0000377]| abnormal hair follicle orientation [MP:0000383]| alopecia [MP:0000414]| sparse hair [MP:0000416]| ruffled hair [MP:0000420]| cortical renal glomerulopathies [MP:0000523]| abnormal femur morphology [MP:0000559]| abnormal hepatocyte morphology [MP:0000607]| abnormal liver physiology [MP:0000609]| abnormal thyroid gland morphology [MP:0000681]| abnormal immune system morphology [MP:0000685]| enlarged spleen [MP:0000691]| spleen hyperplasia [MP:0000693]| abnormal lymph node size [MP:0000701]| enlarged lymph nodes [MP:0000702]| enlarged thymus [MP:0000709]| abnormal lymphocyte cell number [MP:0000717]| abnormal cerebellum morphology [MP:0000849]| small cerebellum [MP:0000852]| abnormal cerebellar foliation [MP:0000857]| decreased Purkinje cell number [MP:0000880]| thin cerebellar molecular layer [MP:0000890]| demyelination [MP:0000921]| abnormal stellate ganglion morphology [MP:0001017]| arrest of spermatogenesis [MP:0001155]| abnormal skin condition [MP:0001191]| dermatitis [MP:0001194]| skin lesions [MP:0001212]| thick epidermis [MP:0001219]| epidermal necrosis [MP:0001220]| increased body weight [MP:0001260]| decreased body size [MP:0001265]| absent vibrissae [MP:0001284]| abnormal lacrimal gland morphology [MP:0001346]| ataxia [MP:0001393]| impaired coordination [MP:0001405]| abnormal spatial learning [MP:0001463]| abnormal cardiovascular system physiology [MP:0001544]| focal hepatic necrosis [MP:0001656]| extended life span [MP:0001661]| abnormal immune system physiology [MP:0001790]| abnormal humoral immune response [MP:0001800]| arrested B cell differentiation [MP:0001802]| decreased IgG level [MP:0001805]| decreased IgM level [MP:0001806]| decreased IgA level [MP:0001807]| increased activated T cell number [MP:0001829]| decreased activated T cell number [MP:0001830]| autoimmune response [MP:0001844]| brain inflammation [MP:0001847]| conjunctivitis [MP:0001852]| kidney inflammation [MP:0001859]| liver inflammation [MP:0001860]| lung inflammation [MP:0001861]| vascular inflammation [MP:0001863]| vasculitis [MP:0001864]| salivary gland inflammation [MP:0001870]| male infertility [MP:0001925]| female infertility [MP:0001926]| increased tumor incidence [MP:0002020]| premature death [MP:0002083]| abnormal kidney morphology [MP:0002135]| abnormal kidney physiology [MP:0002136]| abnormal gland morphology [MP:0002163]| decreased brain weight [MP:0002175]| abnormal outer ear morphology [MP:0002177]| small lymph nodes [MP:0002217]| abnormal spleen size [MP:0002224]| abnormal airway responsiveness [MP:0002334]| abnormal lymph node morphology [MP:0002339]| abnormal thymus medulla morphology [MP:0002375]| increased susceptibility to bacterial infection [MP:0002412]| increased susceptibility to viral infection [MP:0002418]| abnormal CD4-positive [MP:0002432]| alpha beta T cell morphology [MP:0002435]| abnormal effector T cell morphology [MP:0002444]| abnormal T cell physiology [MP:0002458]| abnormal B cell number [MP:0002460]| decreased immunoglobulin level [MP:0002461]| increased immunoglobulin level [MP:0002490]| abnormal immunoglobulin level [MP:0002492]| decreased IgE level [MP:0002493]| increased IgG level [MP:0002494]| increased IgM level [MP:0002495]| increased IgA level [MP:0002497]| increased IgE level [MP:0002533]| abnormal type III hypersensitivity reaction [MP:0002687]| oligozoospermia [MP:0002722]| abnormal immune system organ morphology [MP:0002743]| glomerulonephritis [MP:0002828]| abnormal renal glomerular capsule morphology [MP:0002871]| albuminuria [MP:0002936]| joint swelling [MP:0002962]| increased urine protein level [MP:0002965]| increased circulating serum albumin level [MP:0003009]| abnormal cytokine secretion [MP:0003204]| decreased neuron apoptosis [MP:0003504]| thyroid inflammation [MP:0003606]| kidney failure [MP:0003628]| abnormal leukocyte adhesion [MP:0003644]| thymus atrophy [MP:0003670]| dilated renal glomerular capsule [MP:0003725]| increased autoantibody level [MP:0003726]| decreased autoantibody level [MP:0003793]| abnormal submandibular gland morphology [MP:0003944]| abnormal T cell subpopulation ratio [MP:0003946]| renal necrosis [MP:0004031]| insulitis [MP:0004111]| abnormal coronary artery morphology [MP:0004153]| increased renal tubule apoptosis [MP:0004367]| abnormal strial intermediate cell morphology [MP:0004368]| abnormal stria vascularis vasculature morphology [MP:0004481]| abnormal conjunctival epithelium morphology [MP:0004696]| abnormal thyroid follicle morphology [MP:0004762]| increased anti-double stranded DNA antibody level [MP:0004771]| increased anti-single stranded DNA antibody level [MP:0004794]| increased anti-nuclear antigen antibody level [MP:0004795]| decreased anti-nuclear antigen antibody level [MP:0004796]| increased anti-histone antibody level [MP:0004797]| increased anti-erythrocyte antigen antibody level [MP:0004798]| decreased anti-double stranded DNA antibody level [MP:0004801]| increased susceptibility to systemic lupus erythematosus [MP:0004802]| decreased susceptibility to systemic lupus erythematosus [MP:0004803]| increased susceptibility to autoimmune diabetes [MP:0004804]| decreased susceptibility to autoimmune diabetes [MP:0004829]| increased anti-chromatin antibody level [MP:0004939]| abnormal B cell morphology [MP:0004952]| increased spleen weight [MP:0004953]| decreased spleen weight [MP:0004955]| increased thymus weight [MP:0004977]| increased B-1 B cell number [MP:0005012]| decreased eosinophil cell number [MP:0005014]| increased B cell number [MP:0005015]| increased T cell number [MP:0005017]| decreased B cell number [MP:0005078]| abnormal cytotoxic T cell physiology [MP:0005089]| decreased double-negative T cell number [MP:0005090]| increased double-negative T cell number [MP:0005094]| abnormal T cell proliferation [MP:0005178]| increased circulating cholesterol level [MP:0005179]| decreased circulating cholesterol level [MP:0005264]| glomerulosclerosis [MP:0005265]| abnormal blood urea nitrogen level [MP:0005325]| abnormal renal glomerulus morphology [MP:0005329]| abnormal myocardium layer morphology [MP:0005338]| atherosclerotic lesions [MP:0005339]| increased susceptibility to atherosclerosis [MP:0005350]| increased susceptibility to autoimmune disorder [MP:0005351]| decreased susceptibility to autoimmune disorder [MP:0005416]| abnormal circulating protein level [MP:0005425]| increased macrophage cell number [MP:0005466]| abnormal T-helper 2 physiology [MP:0005554]| decreased circulating creatinine level [MP:0005565]| increased blood urea nitrogen level [MP:0005566]| decreased blood urea nitrogen level [MP:0005568]| increased circulating total protein level [MP:0005584]| abnormal enzyme/coenzyme activity [MP:0005614]| decreased susceptibility to type III hypersensitivity reaction [MP:0005615]| increased susceptibility to type III hypersensitivity reaction [MP:0005621]| abnormal cell physiology [MP:0006042]| increased apoptosis [MP:0006043]| decreased apoptosis [MP:0006055]| abnormal vascular endothelial cell morphology [MP:0006082]| CNS inflammation [MP:0006099]| thin cerebellar granule layer [MP:0006315]| abnormal urine protein level [MP:0006387]| abnormal T cell number [MP:0008037]| abnormal T cell morphology [MP:0008049]| increased memory T cell number [MP:0008056]| abnormal retinal ganglion cell morphology [MP:0008074]| increased CD4-positive [MP:0008075]| alpha beta T cell number [MP:0008078]| decreased CD4-positive [MP:0008079]| alpha beta T cell number [MP:0008097]| increased CD8-positive [MP:0008098]| alpha-beta T cell number [MP:0008102]| decreased CD8-positive [MP:0008126]| alpha-beta T cell number [MP:0008136]| increased plasma cell number [MP:0008139]| decreased plasma cell number [MP:0008140]| lymph node hyperplasia [MP:0008173]| increased dendritic cell number [MP:0008180]| enlarged Peyer's patches [MP:0008181]| fused podocyte foot processes [MP:0008182]| podocyte foot process effacement [MP:0008189]| increased follicular B cell number [MP:0008190]| abnormal marginal zone B cell morphology [MP:0008206]| increased marginal zone B cell number [MP:0008211]| decreased marginal zone B cell number [MP:0008214]| increased transitional stage B cell number [MP:0008215]| decreased transitional stage B cell number [MP:0008217]| increased B-2 B cell number [MP:0008246]| decreased mature B cell number [MP:0008346]| increased immature B cell number [MP:0008350]| decreased immature B cell number [MP:0008477]| abnormal B cell activation [MP:0008478]| abnormal leukocyte morphology [MP:0008481]| increased gamma-delta T cell number [MP:0008482]| increased gamma-delta intraepithelial T cell number [MP:0008495]| decreased spleen red pulp amount [MP:0008496]| increased spleen white pulp amount [MP:0008497]| increased spleen germinal center number [MP:0008498]| decreased spleen germinal center number [MP:0008499]| decreased IgG1 level [MP:0008500]| decreased IgG2a level [MP:0008501]| decreased IgG2b level [MP:0008502]| decreased IgG3 level [MP:0008542]| increased IgG1 level [MP:0008567]| increased IgG2a level [MP:0008573]| increased IgG2b level [MP:0008578]| increased IgG3 level [MP:0008602]| enlarged cervical lymph nodes [MP:0008626]| decreased interferon-gamma secretion [MP:0008688]| increased circulating interferon-alpha level [MP:0008699]| decreased circulating interferon-gamma level [MP:0008713]| increased circulating interleukin-4 level [MP:0008721]| increased circulating interleukin-5 level [MP:0008722]| decreased interleukin-2 secretion [MP:0008750]| increased interleukin-4 secretion [MP:0008751]| abnormal cytokine level [MP:0008752]| abnormal chemokine level [MP:0008766]| abnormal chemokine secretion [MP:0008769]| abnormal interferon level [MP:0008783]| abnormal interleukin level [MP:0008826]| abnormal tumor necrosis factor level [MP:0008828]| abnormal B cell receptor editing [MP:0008879]| abnormal plasmacytoid dendritic cell physiology [MP:0008880]| decreased B cell apoptosis [MP:0008891]| abnormal splenic cell ratio [MP:0008978]| abnormal lymph node cell ratio [MP:0009338]| submandibular gland inflammation [MP:0009346]| lacrimal gland inflammation [MP:0009642]| decreased hepatocyte apoptosis [MP:0009643]| abnormal vagina weight [MP:0009763]| increased splenocyte number [MP:0010065]| decreased trabecular bone thickness [MP:0010138]| abnormal blood homeostasis [MP:0010760]| abnormal urine homeostasis [MP:0010766]| increased sensitivity to induced morbidity/mortality [MP:0010869]| decreased circulating creatine level [MP:0010879]| arteritis [MP:0010933]| abnormal macrophage chemotaxis [MP:0011081]| abnormal NK cell physiology [MP:0011294]| decreased bone trabecula number [MP:0011320]| decreased trabecular bone volume [MP:0011346]| decreased trabecular bone connectivity density [MP:0011348]| decreased macrophage apoptosis [MP:0011353]| renal glomerulus hypertrophy [MP:0011368]| abnormal glomerular capillary morphology [MP:0011369]| renal tubule atrophy [MP:0011377]| abnormal renal glomerulus basement membrane morphology [MP:0011402]| expanded mesangial matrix [MP:0011409]| increased kidney apoptosis [MP:0011427]| increased renal glomerulus apoptosis [MP:0011440]| renal glomerulus fibrosis [MP:0011445]| renal cast [MP:0011453]| increased renal glomerulus basement membrane thickness [MP:0011483]| mesangial cell hyperplasia [MP:0011506]| increased kidney cell proliferation [MP:0011567]| abnormal renal protein reabsorption [MP:0011742]| abnormal glomerular capillary endothelium morphology [MP:0011967]| renal glomerular synechia [MP:0013452]| glomerular crescent [MP:0013455]| increased renal glomerulus lobularity [MP:0013585]| decreased urine nitrite level [MP:0020332]| increased or absent threshold for auditory brainstem response [MP:0020518]| increased lacrimal gland apoptosis [MP:0020519] | |Igh-8||Fas | 015868-MU | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_15868-MU, MMRRC_015868, MMRRC_15868 | 2026-07-25 09:38:13 | 0 | ||||
|
NOD.Cg-Cd28tm1Mak Cd40tm1Kik Ifngtm1Ts H2h4/HbmMmmh Resource Report Resource Website 1+ mentions Issue |
RRID:MMRRC_037143-MU | Mus musculus | Research areas: Immunology and Inflammation; Mutation Type: Targeted Mutation ; Collection: Mullen | increased leukocyte cell number [MP:0000218]| increased monocyte cell number [MP:0000220]| extramedullary hematopoiesis [MP:0000240]| increased granulocyte number [MP:0000322]| abnormal spleen morphology [MP:0000689]| enlarged spleen [MP:0000691]| abnormal lymph node size [MP:0000701]| enlarged lymph nodes [MP:0000702]| increased body weight [MP:0001260]| decreased body weight [MP:0001262]| increased metastatic potential [MP:0001272]| abnormal response to new environment [MP:0001413]| altered susceptibility to infection [MP:0001793]| abnormal humoral immune response [MP:0001800]| decreased IgG level [MP:0001805]| decreased IgM level [MP:0001806]| decreased IgA level [MP:0001807]| abnormal inflammatory response [MP:0001845]| increased inflammatory response [MP:0001846]| brain inflammation [MP:0001847]| kidney inflammation [MP:0001859]| liver inflammation [MP:0001860]| lung inflammation [MP:0001861]| stomach inflammation [MP:0001873]| decreased inflammatory response [MP:0001876]| abnormal lactation [MP:0001882]| mammary gland alveolar hyperplasia [MP:0001884]| decreased litter size [MP:0001935]| abnormal lung volume [MP:0001942]| increased airway responsiveness [MP:0001952]| emphysema [MP:0001958]| increased B cell derived lymphoma incidence [MP:0002023]| increased T cell derived lymphoma incidence [MP:0002024]| increased lung adenocarcinoma incidence [MP:0002027]| increased sarcoma incidence [MP:0002032]| increased carcinoma incidence [MP:0002038]| increased pituitary adenoma incidence [MP:0002041]| decreased tumor incidence [MP:0002052]| premature death [MP:0002083]| abnormal spleen size [MP:0002224]| abnormal pulmonary alveolus morphology [MP:0002270]| decreased airway responsiveness [MP:0002335]| abnormal lymph node cortex morphology [MP:0002343]| abnormal lymph node primary follicle morphology [MP:0002345]| abnormal lymph node secondary follicle morphology [MP:0002346]| abnormal spleen red pulp morphology [MP:0002356]| abnormal spleen white pulp morphology [MP:0002357]| abnormal dendritic cell physiology [MP:0002376]| increased susceptibility to bacterial infection [MP:0002412]| increased susceptibility to viral infection [MP:0002418]| abnormal adaptive immunity [MP:0002420]| altered susceptibility to autoimmune disorder [MP:0002425]| abnormal macrophage physiology [MP:0002451]| abnormal dendritic cell antigen presentation [MP:0002455]| abnormal B cell physiology [MP:0002459]| decreased immunoglobulin level [MP:0002460]| increased immunoglobulin level [MP:0002461]| abnormal immunoglobulin level [MP:0002490]| decreased IgE level [MP:0002492]| increased IgE level [MP:0002497]| abnormal type IV hypersensitivity reaction [MP:0002534]| glomerulonephritis [MP:0002743]| decreased vertical activity [MP:0002757]| albuminuria [MP:0002871]| increased circulating alanine transaminase level [MP:0002941]| abnormal cytokine secretion [MP:0003009]| abnormal redox activity [MP:0003186]| small intestinal inflammation [MP:0003306]| abnormal tumor morphology [MP:0003448]| increased fear-related response [MP:0003459]| abnormal pancreatic beta cell physiology [MP:0003562]| increased ovarian carcinoma incidence [MP:0003579]| increased autoantibody level [MP:0003725]| decreased autoantibody level [MP:0003726]| abnormal nitric oxide homeostasis [MP:0003957]| abnormal lung vasculature morphology [MP:0004007]| abnormal maternal decidual layer morphology [MP:0004256]| decreased length of allograft survival [MP:0004752]| decreased anti-nuclear antigen antibody level [MP:0004795]| decreased anti-double stranded DNA antibody level [MP:0004798]| increased susceptibility to experimental autoimmune encephalomyelitis [MP:0004799]| decreased susceptibility to systemic lupus erythematosus [MP:0004802]| decreased susceptibility to autoimmune diabetes [MP:0004804]| abnormal immune tolerance [MP:0005000]| increased eosinophil cell number [MP:0005011]| increased lymphocyte cell number [MP:0005013]| increased T cell number [MP:0005015]| abnormal response to infection [MP:0005025]| decreased susceptibility to parasitic infection [MP:0005026]| increased susceptibility to parasitic infection [MP:0005027]| abnormal MHC II cell surface expression on macrophages [MP:0005040]| impaired natural killer cell mediated cytotoxicity [MP:0005070]| abnormal cytotoxic T cell physiology [MP:0005078]| decreased double-negative T cell number [MP:0005089]| cachexia [MP:0005150]| abnormal response to injury [MP:0005164]| decreased susceptibility to injury [MP:0005166]| abnormal renal glomerulus morphology [MP:0005325]| atherosclerotic lesions [MP:0005338]| decreased susceptibility to autoimmune disorder [MP:0005351]| abnormal Langerhans cell physiology [MP:0005362]| increased susceptibility to fungal infection [MP:0005399]| abnormal skin physiology [MP:0005501]| corneal vascularization [MP:0005542]| decreased circulating creatinine level [MP:0005554]| increased blood urea nitrogen level [MP:0005565]| decreased susceptibility to type IV hypersensitivity reaction [MP:0005616]| increased susceptibility to type IV hypersensitivity reaction [MP:0005617]| abnormal response to transplant [MP:0005671]| abnormal mammary gland growth during pregnancy [MP:0006269]| increased NK T cell number [MP:0008039]| abnormal uterine NK cell morphology [MP:0008054]| increased CD4-positive [MP:0008074]| alpha beta T cell number [MP:0008078]| increased CD8-positive [MP:0008135]| alpha-beta T cell number [MP:0008466]| small Peyer's patches [MP:0008474]| enlarged mesenteric lymph nodes [MP:0008496]| absent spleen germinal center [MP:0008497]| decreased IgG2a level [MP:0008498]| decreased IgG2b level [MP:0008499]| decreased IgG3 level [MP:0008523]| increased IgG1 level [MP:0008567]| absent lymph node germinal center [MP:0008596]| decreased interferon-gamma secretion [MP:0008660]| increased circulating interleukin-6 level [MP:0008661]| increased interleukin-10 secretion [MP:0008663]| decreased interleukin-10 secretion [MP:0008681]| increased interleukin-12 secretion [MP:0008687]| increased interleukin-17 secretion [MP:0008699]| increased interleukin-2 secretion [MP:0008702]| increased interleukin-4 secretion [MP:0008713]| increased interleukin-5 secretion [MP:0008770]| abnormal cytokine level [MP:0008828]| decreased survivor rate [MP:0008874]| abnormal lymph node cell ratio [MP:0009099]| decreased physiological sensitivity to xenobiotic [MP:0009246]| abnormal uterine NK cell physiology [MP:0009336]| pale spleen [MP:0009394]| increased splenocyte proliferation [MP:0009419]| increased uterine NK cell number [MP:0009643]| skeletal muscle fibrosis [MP:0009763]| abnormal urine homeostasis [MP:0009766]| increased sensitivity to induced morbidity/mortality [MP:0009788]| increased sensitivity to xenobiotic induced morbidity/mortality [MP:0009791]| increased susceptibility to bacterial infection induced morbidity/mortality [MP:0009828]| increased susceptibility to viral infection induced morbidity/mortality [MP:0010210]| increased tumor latency [MP:0010308]| abnormal circulating cytokine level [MP:0010574]| decreased tumor latency [MP:0010639]| aorta dilation [MP:0010659]| altered tumor pathology [MP:0010740]| abdominal aorta aneurysm [MP:0010750]| abnormal dendritic cell chemotaxis [MP:0010751]| increased susceptibility to parasitic infection induced morbidity/mortality [MP:0010760]| decreased susceptibility to parasitic infection induced morbidity/mortality [MP:0010766]| abnormal macrophage chemotaxis [MP:0011086]| abnormal NK cell physiology [MP:0011320]| postnatal lethality [MP:0011427]| incomplete penetrance [MP:0012431]| abnormal glomerular capillary morphology [MP:0013239]| mesangial cell hyperplasia [MP:0013590]| increased lymphoma incidence [MP:0030466]| decreased bone mineral density [MP:0000063]| decreased neutrophil cell number [MP:0000222]| enlarged spleen [MP:0000691]| enlarged lymph nodes [MP:0000702]| abnormal humoral immune response [MP:0001800]| decreased IgA level [MP:0001807]| no abnormal phenotype detected [MP:0002169]| abnormal thymus medulla morphology [MP:0002375]| abnormal dendritic cell physiology [MP:0002376]| increased susceptibility to bacterial infection [MP:0002412]| abnormal B cell physiology [MP:0002459]| decreased immunoglobulin level [MP:0002460]| decreased IgE level [MP:0002492]| glomerulonephritis [MP:0002743]| increased urine protein level [MP:0002962]| increased anti-double stranded DNA antibody level [MP:0004762]| abnormal class switch recombination [MP:0004816]| decreased B cell number [MP:0005017]| decreased susceptibility to type II hypersensitivity reaction [MP:0005612]| decreased cerebral infarction size [MP:0006058]| increased follicular B cell number [MP:0008173]| absent germinal center B cells [MP:0008179]| increased marginal zone B cell number [MP:0008181]| increased transitional stage B cell number [MP:0008189]| abnormal B cell activation [MP:0008217]| absent spleen germinal center [MP:0008474]| decreased IgG1 level [MP:0008495]| decreased IgG2a level [MP:0008496]| decreased IgG2b level [MP:0008497]| decreased IgG3 level [MP:0008498]| abnormal thymus epithelium morphology [MP:0009544]| decreased platelet aggregation [MP:0009549]| decreased trabecular bone mass [MP:0010873]| decreased compact bone mass [MP:0010962]| renal glomerular immunoglobulin deposits [MP:0020519]| abnormal cytokine secretion [MP:0003009]| thyroid inflammation [MP:0003504]| insulitis [MP:0004031]| decreased susceptibility to autoimmune diabetes [MP:0004804]| periinsulitis [MP:0005580]| decreased physiological sensitivity to xenobiotic [MP:0008874]| abnormal esophageal epithelium morphology [MP:0000468]| enlarged thymus [MP:0000709]| increased activated T cell number [MP:0001829]| brain inflammation [MP:0001847]| increased T cell derived lymphoma incidence [MP:0002024]| abnormal T cell differentiation [MP:0002145]| abnormal lymphopoiesis [MP:0002401]| decreased immunoglobulin level [MP:0002460]| abnormal cytokine secretion [MP:0003009]| esophageal inflammation [MP:0003278]| insulitis [MP:0004031]| increased length of allograft survival [MP:0004751]| decreased susceptibility to experimental autoimmune encephalomyelitis [MP:0004800]| increased susceptibility to autoimmune diabetes [MP:0004803]| abnormal class switch recombination [MP:0004816]| abnormal regulatory T cell physiology [MP:0004946]| decreased regulatory T cell number [MP:0004974]| abnormal T cell clonal deletion [MP:0005002]| increased eosinophil cell number [MP:0005011]| increased susceptibility to parasitic infection [MP:0005027]| abnormal cytotoxic T cell physiology [MP:0005078]| decreased cytotoxic T cell cytolysis [MP:0005079]| decreased T cell proliferation [MP:0005095]| increased T cell proliferation [MP:0005348]| abnormal CD4-positive [MP:0005463]| alpha-beta T cell physiology [MP:0005465]| abnormal T-helper 1 physiology [MP:0005466]| abnormal T-helper 2 physiology [MP:0005596]| increased susceptibility to type I hypersensitivity reaction [MP:0005671]| abnormal response to transplant [MP:0006413]| increased T cell apoptosis [MP:0008049]| increased memory T cell number [MP:0008074]| increased CD4-positive [MP:0008078]| alpha beta T cell number [MP:0008192]| increased CD8-positive [MP:0008482]| alpha-beta T cell number [MP:0008495]| abnormal germinal center B cell physiology [MP:0008496]| decreased spleen germinal center number [MP:0008497]| decreased IgG1 level [MP:0008500]| decreased IgG2a level [MP:0008566]| decreased IgG2b level [MP:0008567]| increased IgG2a level [MP:0008578]| increased interferon-gamma secretion [MP:0008603]| decreased interferon-gamma secretion [MP:0008687]| decreased circulating interferon-gamma level [MP:0008688]| decreased circulating interleukin-4 level [MP:0008699]| increased interleukin-2 secretion [MP:0008700]| decreased interleukin-2 secretion [MP:0008747]| increased interleukin-4 secretion [MP:0009335]| decreased interleukin-4 secretion [MP:0010268]| abnormal T cell anergy [MP:0010766] | Cd28||Ifng||Cd40||| | 037143-MU | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_37143-MU, MMRRC_037143, MMRRC_37143 | 2026-07-25 09:42:11 | 1 | ||||
|
NOD.Cg-Ifngtm1Ts H2h4 Tg(tetO-Tcra)1Doi/HbmMmmh Resource Report Resource Website Issue |
RRID:MMRRC_037147-MU | Mus musculus | Research areas: Immunology and Inflammation; Mutation Type: Transgenic ; Collection: Mullen | increased leukocyte cell number [MP:0000218]| increased monocyte cell number [MP:0000220]| extramedullary hematopoiesis [MP:0000240]| increased granulocyte number [MP:0000322]| abnormal spleen morphology [MP:0000689]| enlarged spleen [MP:0000691]| abnormal lymph node size [MP:0000701]| enlarged lymph nodes [MP:0000702]| increased body weight [MP:0001260]| decreased body weight [MP:0001262]| increased metastatic potential [MP:0001272]| abnormal response to new environment [MP:0001413]| altered susceptibility to infection [MP:0001793]| abnormal humoral immune response [MP:0001800]| decreased IgG level [MP:0001805]| decreased IgM level [MP:0001806]| decreased IgA level [MP:0001807]| abnormal inflammatory response [MP:0001845]| increased inflammatory response [MP:0001846]| brain inflammation [MP:0001847]| kidney inflammation [MP:0001859]| liver inflammation [MP:0001860]| lung inflammation [MP:0001861]| stomach inflammation [MP:0001873]| decreased inflammatory response [MP:0001876]| abnormal lactation [MP:0001882]| mammary gland alveolar hyperplasia [MP:0001884]| decreased litter size [MP:0001935]| abnormal lung volume [MP:0001942]| increased airway responsiveness [MP:0001952]| emphysema [MP:0001958]| increased B cell derived lymphoma incidence [MP:0002023]| increased T cell derived lymphoma incidence [MP:0002024]| increased lung adenocarcinoma incidence [MP:0002027]| increased sarcoma incidence [MP:0002032]| increased carcinoma incidence [MP:0002038]| increased pituitary adenoma incidence [MP:0002041]| decreased tumor incidence [MP:0002052]| premature death [MP:0002083]| abnormal spleen size [MP:0002224]| abnormal pulmonary alveolus morphology [MP:0002270]| decreased airway responsiveness [MP:0002335]| abnormal lymph node cortex morphology [MP:0002343]| abnormal lymph node primary follicle morphology [MP:0002345]| abnormal lymph node secondary follicle morphology [MP:0002346]| abnormal spleen red pulp morphology [MP:0002356]| abnormal spleen white pulp morphology [MP:0002357]| abnormal dendritic cell physiology [MP:0002376]| increased susceptibility to bacterial infection [MP:0002412]| increased susceptibility to viral infection [MP:0002418]| abnormal adaptive immunity [MP:0002420]| altered susceptibility to autoimmune disorder [MP:0002425]| abnormal macrophage physiology [MP:0002451]| abnormal dendritic cell antigen presentation [MP:0002455]| abnormal B cell physiology [MP:0002459]| decreased immunoglobulin level [MP:0002460]| increased immunoglobulin level [MP:0002461]| abnormal immunoglobulin level [MP:0002490]| decreased IgE level [MP:0002492]| increased IgE level [MP:0002497]| abnormal type IV hypersensitivity reaction [MP:0002534]| glomerulonephritis [MP:0002743]| decreased vertical activity [MP:0002757]| albuminuria [MP:0002871]| increased circulating alanine transaminase level [MP:0002941]| abnormal cytokine secretion [MP:0003009]| abnormal redox activity [MP:0003186]| small intestinal inflammation [MP:0003306]| abnormal tumor morphology [MP:0003448]| increased fear-related response [MP:0003459]| abnormal pancreatic beta cell physiology [MP:0003562]| increased ovarian carcinoma incidence [MP:0003579]| increased autoantibody level [MP:0003725]| decreased autoantibody level [MP:0003726]| abnormal nitric oxide homeostasis [MP:0003957]| abnormal lung vasculature morphology [MP:0004007]| abnormal maternal decidual layer morphology [MP:0004256]| decreased length of allograft survival [MP:0004752]| decreased anti-nuclear antigen antibody level [MP:0004795]| decreased anti-double stranded DNA antibody level [MP:0004798]| increased susceptibility to experimental autoimmune encephalomyelitis [MP:0004799]| decreased susceptibility to systemic lupus erythematosus [MP:0004802]| decreased susceptibility to autoimmune diabetes [MP:0004804]| abnormal immune tolerance [MP:0005000]| increased eosinophil cell number [MP:0005011]| increased lymphocyte cell number [MP:0005013]| increased T cell number [MP:0005015]| abnormal response to infection [MP:0005025]| decreased susceptibility to parasitic infection [MP:0005026]| increased susceptibility to parasitic infection [MP:0005027]| abnormal MHC II cell surface expression on macrophages [MP:0005040]| impaired natural killer cell mediated cytotoxicity [MP:0005070]| abnormal cytotoxic T cell physiology [MP:0005078]| decreased double-negative T cell number [MP:0005089]| cachexia [MP:0005150]| abnormal response to injury [MP:0005164]| decreased susceptibility to injury [MP:0005166]| abnormal renal glomerulus morphology [MP:0005325]| atherosclerotic lesions [MP:0005338]| decreased susceptibility to autoimmune disorder [MP:0005351]| abnormal Langerhans cell physiology [MP:0005362]| increased susceptibility to fungal infection [MP:0005399]| abnormal skin physiology [MP:0005501]| corneal vascularization [MP:0005542]| decreased circulating creatinine level [MP:0005554]| increased blood urea nitrogen level [MP:0005565]| decreased susceptibility to type IV hypersensitivity reaction [MP:0005616]| increased susceptibility to type IV hypersensitivity reaction [MP:0005617]| abnormal response to transplant [MP:0005671]| abnormal mammary gland growth during pregnancy [MP:0006269]| increased NK T cell number [MP:0008039]| abnormal uterine NK cell morphology [MP:0008054]| increased CD4-positive [MP:0008074]| alpha beta T cell number [MP:0008078]| increased CD8-positive [MP:0008135]| alpha-beta T cell number [MP:0008466]| small Peyer's patches [MP:0008474]| enlarged mesenteric lymph nodes [MP:0008496]| absent spleen germinal center [MP:0008497]| decreased IgG2a level [MP:0008498]| decreased IgG2b level [MP:0008499]| decreased IgG3 level [MP:0008523]| increased IgG1 level [MP:0008567]| absent lymph node germinal center [MP:0008596]| decreased interferon-gamma secretion [MP:0008660]| increased circulating interleukin-6 level [MP:0008661]| increased interleukin-10 secretion [MP:0008663]| decreased interleukin-10 secretion [MP:0008681]| increased interleukin-12 secretion [MP:0008687]| increased interleukin-17 secretion [MP:0008699]| increased interleukin-2 secretion [MP:0008702]| increased interleukin-4 secretion [MP:0008713]| increased interleukin-5 secretion [MP:0008770]| abnormal cytokine level [MP:0008828]| decreased survivor rate [MP:0008874]| abnormal lymph node cell ratio [MP:0009099]| decreased physiological sensitivity to xenobiotic [MP:0009246]| abnormal uterine NK cell physiology [MP:0009336]| pale spleen [MP:0009394]| increased splenocyte proliferation [MP:0009419]| increased uterine NK cell number [MP:0009643]| skeletal muscle fibrosis [MP:0009763]| abnormal urine homeostasis [MP:0009766]| increased sensitivity to induced morbidity/mortality [MP:0009788]| increased sensitivity to xenobiotic induced morbidity/mortality [MP:0009791]| increased susceptibility to bacterial infection induced morbidity/mortality [MP:0009828]| increased susceptibility to viral infection induced morbidity/mortality [MP:0010210]| increased tumor latency [MP:0010308]| abnormal circulating cytokine level [MP:0010574]| decreased tumor latency [MP:0010639]| aorta dilation [MP:0010659]| altered tumor pathology [MP:0010740]| abdominal aorta aneurysm [MP:0010750]| abnormal dendritic cell chemotaxis [MP:0010751]| increased susceptibility to parasitic infection induced morbidity/mortality [MP:0010760]| decreased susceptibility to parasitic infection induced morbidity/mortality [MP:0010766]| abnormal macrophage chemotaxis [MP:0011086]| abnormal NK cell physiology [MP:0011320]| postnatal lethality [MP:0011427]| incomplete penetrance [MP:0012431]| abnormal glomerular capillary morphology [MP:0013239]| mesangial cell hyperplasia [MP:0013590]| increased lymphoma incidence [MP:0030466]| abnormal cytokine secretion [MP:0003009]| thyroid inflammation [MP:0003504]| insulitis [MP:0004031]| decreased susceptibility to autoimmune diabetes [MP:0004804]| periinsulitis [MP:0005580]| decreased physiological sensitivity to xenobiotic [MP:0008874] | |Tcra|||Ifng| | 037147-MU | Transgenic | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | PMID:22298883 | MMRRC_37147-MU, MMRRC_037147, MMRRC_37147 | 2026-07-25 09:42:11 | 0 | |||
|
NOD.Cg-Cd28tm1Mak Ifngtm1Ts H2h4/HbmMmmh Resource Report Resource Website 1+ mentions Issue |
RRID:MMRRC_037141-MU | Mus musculus | Research areas: Immunology and Inflammation; Mutation Type: Targeted Mutation ; Collection: Mullen | increased leukocyte cell number [MP:0000218]| increased monocyte cell number [MP:0000220]| extramedullary hematopoiesis [MP:0000240]| increased granulocyte number [MP:0000322]| abnormal spleen morphology [MP:0000689]| enlarged spleen [MP:0000691]| abnormal lymph node size [MP:0000701]| enlarged lymph nodes [MP:0000702]| increased body weight [MP:0001260]| decreased body weight [MP:0001262]| increased metastatic potential [MP:0001272]| abnormal response to new environment [MP:0001413]| altered susceptibility to infection [MP:0001793]| abnormal humoral immune response [MP:0001800]| decreased IgG level [MP:0001805]| decreased IgM level [MP:0001806]| decreased IgA level [MP:0001807]| abnormal inflammatory response [MP:0001845]| increased inflammatory response [MP:0001846]| brain inflammation [MP:0001847]| kidney inflammation [MP:0001859]| liver inflammation [MP:0001860]| lung inflammation [MP:0001861]| stomach inflammation [MP:0001873]| decreased inflammatory response [MP:0001876]| abnormal lactation [MP:0001882]| mammary gland alveolar hyperplasia [MP:0001884]| decreased litter size [MP:0001935]| abnormal lung volume [MP:0001942]| increased airway responsiveness [MP:0001952]| emphysema [MP:0001958]| increased B cell derived lymphoma incidence [MP:0002023]| increased T cell derived lymphoma incidence [MP:0002024]| increased lung adenocarcinoma incidence [MP:0002027]| increased sarcoma incidence [MP:0002032]| increased carcinoma incidence [MP:0002038]| increased pituitary adenoma incidence [MP:0002041]| decreased tumor incidence [MP:0002052]| premature death [MP:0002083]| abnormal spleen size [MP:0002224]| abnormal pulmonary alveolus morphology [MP:0002270]| decreased airway responsiveness [MP:0002335]| abnormal lymph node cortex morphology [MP:0002343]| abnormal lymph node primary follicle morphology [MP:0002345]| abnormal lymph node secondary follicle morphology [MP:0002346]| abnormal spleen red pulp morphology [MP:0002356]| abnormal spleen white pulp morphology [MP:0002357]| abnormal dendritic cell physiology [MP:0002376]| increased susceptibility to bacterial infection [MP:0002412]| increased susceptibility to viral infection [MP:0002418]| abnormal adaptive immunity [MP:0002420]| altered susceptibility to autoimmune disorder [MP:0002425]| abnormal macrophage physiology [MP:0002451]| abnormal dendritic cell antigen presentation [MP:0002455]| abnormal B cell physiology [MP:0002459]| decreased immunoglobulin level [MP:0002460]| increased immunoglobulin level [MP:0002461]| abnormal immunoglobulin level [MP:0002490]| decreased IgE level [MP:0002492]| increased IgE level [MP:0002497]| abnormal type IV hypersensitivity reaction [MP:0002534]| glomerulonephritis [MP:0002743]| decreased vertical activity [MP:0002757]| albuminuria [MP:0002871]| increased circulating alanine transaminase level [MP:0002941]| abnormal cytokine secretion [MP:0003009]| abnormal redox activity [MP:0003186]| small intestinal inflammation [MP:0003306]| abnormal tumor morphology [MP:0003448]| increased fear-related response [MP:0003459]| abnormal pancreatic beta cell physiology [MP:0003562]| increased ovarian carcinoma incidence [MP:0003579]| increased autoantibody level [MP:0003725]| decreased autoantibody level [MP:0003726]| abnormal nitric oxide homeostasis [MP:0003957]| abnormal lung vasculature morphology [MP:0004007]| abnormal maternal decidual layer morphology [MP:0004256]| decreased length of allograft survival [MP:0004752]| decreased anti-nuclear antigen antibody level [MP:0004795]| decreased anti-double stranded DNA antibody level [MP:0004798]| increased susceptibility to experimental autoimmune encephalomyelitis [MP:0004799]| decreased susceptibility to systemic lupus erythematosus [MP:0004802]| decreased susceptibility to autoimmune diabetes [MP:0004804]| abnormal immune tolerance [MP:0005000]| increased eosinophil cell number [MP:0005011]| increased lymphocyte cell number [MP:0005013]| increased T cell number [MP:0005015]| abnormal response to infection [MP:0005025]| decreased susceptibility to parasitic infection [MP:0005026]| increased susceptibility to parasitic infection [MP:0005027]| abnormal MHC II cell surface expression on macrophages [MP:0005040]| impaired natural killer cell mediated cytotoxicity [MP:0005070]| abnormal cytotoxic T cell physiology [MP:0005078]| decreased double-negative T cell number [MP:0005089]| cachexia [MP:0005150]| abnormal response to injury [MP:0005164]| decreased susceptibility to injury [MP:0005166]| abnormal renal glomerulus morphology [MP:0005325]| atherosclerotic lesions [MP:0005338]| decreased susceptibility to autoimmune disorder [MP:0005351]| abnormal Langerhans cell physiology [MP:0005362]| increased susceptibility to fungal infection [MP:0005399]| abnormal skin physiology [MP:0005501]| corneal vascularization [MP:0005542]| decreased circulating creatinine level [MP:0005554]| increased blood urea nitrogen level [MP:0005565]| decreased susceptibility to type IV hypersensitivity reaction [MP:0005616]| increased susceptibility to type IV hypersensitivity reaction [MP:0005617]| abnormal response to transplant [MP:0005671]| abnormal mammary gland growth during pregnancy [MP:0006269]| increased NK T cell number [MP:0008039]| abnormal uterine NK cell morphology [MP:0008054]| increased CD4-positive [MP:0008074]| alpha beta T cell number [MP:0008078]| increased CD8-positive [MP:0008135]| alpha-beta T cell number [MP:0008466]| small Peyer's patches [MP:0008474]| enlarged mesenteric lymph nodes [MP:0008496]| absent spleen germinal center [MP:0008497]| decreased IgG2a level [MP:0008498]| decreased IgG2b level [MP:0008499]| decreased IgG3 level [MP:0008523]| increased IgG1 level [MP:0008567]| absent lymph node germinal center [MP:0008596]| decreased interferon-gamma secretion [MP:0008660]| increased circulating interleukin-6 level [MP:0008661]| increased interleukin-10 secretion [MP:0008663]| decreased interleukin-10 secretion [MP:0008681]| increased interleukin-12 secretion [MP:0008687]| increased interleukin-17 secretion [MP:0008699]| increased interleukin-2 secretion [MP:0008702]| increased interleukin-4 secretion [MP:0008713]| increased interleukin-5 secretion [MP:0008770]| abnormal cytokine level [MP:0008828]| decreased survivor rate [MP:0008874]| abnormal lymph node cell ratio [MP:0009099]| decreased physiological sensitivity to xenobiotic [MP:0009246]| abnormal uterine NK cell physiology [MP:0009336]| pale spleen [MP:0009394]| increased splenocyte proliferation [MP:0009419]| increased uterine NK cell number [MP:0009643]| skeletal muscle fibrosis [MP:0009763]| abnormal urine homeostasis [MP:0009766]| increased sensitivity to induced morbidity/mortality [MP:0009788]| increased sensitivity to xenobiotic induced morbidity/mortality [MP:0009791]| increased susceptibility to bacterial infection induced morbidity/mortality [MP:0009828]| increased susceptibility to viral infection induced morbidity/mortality [MP:0010210]| increased tumor latency [MP:0010308]| abnormal circulating cytokine level [MP:0010574]| decreased tumor latency [MP:0010639]| aorta dilation [MP:0010659]| altered tumor pathology [MP:0010740]| abdominal aorta aneurysm [MP:0010750]| abnormal dendritic cell chemotaxis [MP:0010751]| increased susceptibility to parasitic infection induced morbidity/mortality [MP:0010760]| decreased susceptibility to parasitic infection induced morbidity/mortality [MP:0010766]| abnormal macrophage chemotaxis [MP:0011086]| abnormal NK cell physiology [MP:0011320]| postnatal lethality [MP:0011427]| incomplete penetrance [MP:0012431]| abnormal glomerular capillary morphology [MP:0013239]| mesangial cell hyperplasia [MP:0013590]| increased lymphoma incidence [MP:0030466]| abnormal cytokine secretion [MP:0003009]| thyroid inflammation [MP:0003504]| insulitis [MP:0004031]| decreased susceptibility to autoimmune diabetes [MP:0004804]| periinsulitis [MP:0005580]| decreased physiological sensitivity to xenobiotic [MP:0008874]| abnormal esophageal epithelium morphology [MP:0000468]| enlarged thymus [MP:0000709]| increased activated T cell number [MP:0001829]| brain inflammation [MP:0001847]| increased T cell derived lymphoma incidence [MP:0002024]| abnormal T cell differentiation [MP:0002145]| abnormal lymphopoiesis [MP:0002401]| decreased immunoglobulin level [MP:0002460]| abnormal cytokine secretion [MP:0003009]| esophageal inflammation [MP:0003278]| insulitis [MP:0004031]| increased length of allograft survival [MP:0004751]| decreased susceptibility to experimental autoimmune encephalomyelitis [MP:0004800]| increased susceptibility to autoimmune diabetes [MP:0004803]| abnormal class switch recombination [MP:0004816]| abnormal regulatory T cell physiology [MP:0004946]| decreased regulatory T cell number [MP:0004974]| abnormal T cell clonal deletion [MP:0005002]| increased eosinophil cell number [MP:0005011]| increased susceptibility to parasitic infection [MP:0005027]| abnormal cytotoxic T cell physiology [MP:0005078]| decreased cytotoxic T cell cytolysis [MP:0005079]| decreased T cell proliferation [MP:0005095]| increased T cell proliferation [MP:0005348]| abnormal CD4-positive [MP:0005463]| alpha-beta T cell physiology [MP:0005465]| abnormal T-helper 1 physiology [MP:0005466]| abnormal T-helper 2 physiology [MP:0005596]| increased susceptibility to type I hypersensitivity reaction [MP:0005671]| abnormal response to transplant [MP:0006413]| increased T cell apoptosis [MP:0008049]| increased memory T cell number [MP:0008074]| increased CD4-positive [MP:0008078]| alpha beta T cell number [MP:0008192]| increased CD8-positive [MP:0008482]| alpha-beta T cell number [MP:0008495]| abnormal germinal center B cell physiology [MP:0008496]| decreased spleen germinal center number [MP:0008497]| decreased IgG1 level [MP:0008500]| decreased IgG2a level [MP:0008566]| decreased IgG2b level [MP:0008567]| increased IgG2a level [MP:0008578]| increased interferon-gamma secretion [MP:0008603]| decreased interferon-gamma secretion [MP:0008687]| decreased circulating interferon-gamma level [MP:0008688]| decreased circulating interleukin-4 level [MP:0008699]| increased interleukin-2 secretion [MP:0008700]| decreased interleukin-2 secretion [MP:0008747]| increased interleukin-4 secretion [MP:0009335]| decreased interleukin-4 secretion [MP:0010268]| abnormal T cell anergy [MP:0010766] | Cd28||Ifng||| | 037141-MU | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_37141-MU, MMRRC_037141, MMRRC_37141 | 2026-07-25 09:42:11 | 1 | ||||
|
NOD.Cg-Cd28tm1Mak Ighmtm1Cgn H2h4/HbmMmmh Resource Report Resource Website Issue Issue |
RRID:MMRRC_037353-MU | Mus musculus | Research areas: ; Mutation Type: Targeted Mutation ; Collection: Mullen | decreased bone mineral density [MP:0000063]| abnormal trabecular bone morphology [MP:0000130]| decreased compact bone thickness [MP:0000135]| enlarged heart [MP:0000274]| increased cell proliferation [MP:0000351]| abnormal intestinal epithelium morphology [MP:0000488]| abnormal spleen morphology [MP:0000689]| enlarged lymph nodes [MP:0000702]| abnormal skin condition [MP:0001191]| abnormal cardiovascular system physiology [MP:0001544]| abnormal humoral immune response [MP:0001800]| arrested B cell differentiation [MP:0001802]| decreased IgG level [MP:0001805]| decreased IgM level [MP:0001806]| decreased IgA level [MP:0001807]| thymus hypoplasia [MP:0001823]| abnormal antigen presentation [MP:0001835]| abnormal inflammatory response [MP:0001845]| increased inflammatory response [MP:0001846]| heart inflammation [MP:0001853]| myocarditis [MP:0001856]| kidney inflammation [MP:0001859]| abnormal lymphatic vessel morphology [MP:0001879]| premature death [MP:0002083]| abnormal respiratory system physiology [MP:0002133]| abnormal B cell differentiation [MP:0002144]| abnormal spleen marginal sinus morphology [MP:0002363]| abnormal B lymphocyte antigen presentation [MP:0002453]| decreased immunoglobulin level [MP:0002460]| abnormal immunoglobulin level [MP:0002490]| decreased IgE level [MP:0002492]| tubular nephritis [MP:0002704]| increased urine protein level [MP:0002962]| abnormal cytokine secretion [MP:0003009]| cardiac fibrosis [MP:0003141]| thrombocytopenia [MP:0003179]| small intestinal inflammation [MP:0003306]| increased susceptibility to induced arthritis [MP:0003724]| increased autoantibody level [MP:0003725]| abnormal compact bone morphology [MP:0003797]| abnormal PR interval [MP:0003901]| insulitis [MP:0004031]| decreased susceptibility to systemic lupus erythematosus [MP:0004802]| increased susceptibility to autoimmune diabetes [MP:0004803]| decreased susceptibility to autoimmune diabetes [MP:0004804]| decreased spleen weight [MP:0004953]| increased osteoclast cell number [MP:0004984]| increased T cell number [MP:0005015]| decreased B cell number [MP:0005017]| abnormal response to infection [MP:0005025]| increased susceptibility to parasitic infection [MP:0005027]| abnormal T cell proliferation [MP:0005094]| decreased T cell proliferation [MP:0005095]| cachexia [MP:0005150]| decreased susceptibility to injury [MP:0005166]| abnormal pancreatic islet morphology [MP:0005215]| abnormal CD4-positive [MP:0005463]| alpha-beta T cell physiology [MP:0005559]| increased circulating glucose level [MP:0005616]| decreased susceptibility to type IV hypersensitivity reaction [MP:0006387]| abnormal T cell number [MP:0008071]| absent B cells [MP:0008075]| decreased CD4-positive [MP:0008079]| alpha beta T cell number [MP:0008127]| decreased CD8-positive [MP:0008171]| alpha-beta T cell number [MP:0008201]| decreased dendritic cell number [MP:0008211]| abnormal mature B cell morphology [MP:0008212]| absent follicular dendritic cells [MP:0008213]| decreased mature B cell number [MP:0008240]| absent mature B cells [MP:0008241]| absent immature B cells [MP:0008401]| abnormal spleen marginal zone macrophage morphology [MP:0008470]| abnormal metallophilic macrophage morphology [MP:0008495]| abnormal CD8 positive [MP:0009346]| alpha-beta intraepithelial T cell morphology [MP:0010965]| abnormal spleen B cell follicle morphology [MP:0012431]| abnormal cytokine secretion [MP:0003009]| thyroid inflammation [MP:0003504]| insulitis [MP:0004031]| decreased susceptibility to autoimmune diabetes [MP:0004804]| periinsulitis [MP:0005580]| decreased physiological sensitivity to xenobiotic [MP:0008874]| abnormal esophageal epithelium morphology [MP:0000468]| enlarged thymus [MP:0000709]| increased activated T cell number [MP:0001829]| brain inflammation [MP:0001847]| increased T cell derived lymphoma incidence [MP:0002024]| abnormal T cell differentiation [MP:0002145]| abnormal lymphopoiesis [MP:0002401]| decreased immunoglobulin level [MP:0002460]| abnormal cytokine secretion [MP:0003009]| esophageal inflammation [MP:0003278]| insulitis [MP:0004031]| increased length of allograft survival [MP:0004751]| decreased susceptibility to experimental autoimmune encephalomyelitis [MP:0004800]| increased susceptibility to autoimmune diabetes [MP:0004803]| abnormal class switch recombination [MP:0004816]| abnormal regulatory T cell physiology [MP:0004946]| decreased regulatory T cell number [MP:0004974]| abnormal T cell clonal deletion [MP:0005002]| increased eosinophil cell number [MP:0005011]| increased susceptibility to parasitic infection [MP:0005027]| abnormal cytotoxic T cell physiology [MP:0005078]| decreased cytotoxic T cell cytolysis [MP:0005079]| decreased T cell proliferation [MP:0005095]| increased T cell proliferation [MP:0005348]| abnormal CD4-positive [MP:0005463]| alpha-beta T cell physiology [MP:0005465]| abnormal T-helper 1 physiology [MP:0005466]| abnormal T-helper 2 physiology [MP:0005596]| increased susceptibility to type I hypersensitivity reaction [MP:0005671]| abnormal response to transplant [MP:0006413]| increased T cell apoptosis [MP:0008049]| increased memory T cell number [MP:0008074]| increased CD4-positive [MP:0008078]| alpha beta T cell number [MP:0008192]| increased CD8-positive [MP:0008482]| alpha-beta T cell number [MP:0008495]| abnormal germinal center B cell physiology [MP:0008496]| decreased spleen germinal center number [MP:0008497]| decreased IgG1 level [MP:0008500]| decreased IgG2a level [MP:0008566]| decreased IgG2b level [MP:0008567]| increased IgG2a level [MP:0008578]| increased interferon-gamma secretion [MP:0008603]| decreased interferon-gamma secretion [MP:0008687]| decreased circulating interferon-gamma level [MP:0008688]| decreased circulating interleukin-4 level [MP:0008699]| increased interleukin-2 secretion [MP:0008700]| decreased interleukin-2 secretion [MP:0008747]| increased interleukin-4 secretion [MP:0009335]| decreased interleukin-4 secretion [MP:0010268]| abnormal T cell anergy [MP:0010766] | Cd28||Ighm||| | 037353-MU | Targeted Mutation | Mutant Mouse Resource and Research Center (MMRRC) | MMRRC | MMRRC_37353-MU, MMRRC_037353, MMRRC_37353 | 2026-07-25 09:42:12 | 0 |
Can't find your Organism?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific organism, it's easier to enter an RRID or a Catalog Number to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your organism in the search results, please help us by registering it into the system — it's easy. Organisms identifiers are registered through multiple sources depending on the species:
Welcome to the ASWG Resources search. From here you can search through a compilation of resources used by ASWG and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that ASWG has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on ASWG then you can log in from here to get additional features in ASWG such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into ASWG you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the ASWG Community.
Our Information
